Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

The cost-effectiveness of breast cancer screening.

van der Maas PJ, de Koning HJ, van Ineveld BM, van Oortmarssen GJ, Habbema JD, Lubbe KT, Geerts AT, Collette HJ, Verbeek AL, Hendriks JH, et al.

Int J Cancer. 1989 Jun 15;43(6):1055-60.

PMID:
2499553
2.

Breast cancer screening; cost-effective in practice?

De Koning HJ.

Eur J Radiol. 2000 Jan;33(1):32-7.

PMID:
10674787
3.
4.

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.

de Koning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JC, Collette HJ, Hendriks JH, van der Maas PJ.

Int J Cancer. 1991 Oct 21;49(4):531-7.

PMID:
1917154
5.

Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.

Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ.

J Natl Cancer Inst. 2008 Sep 17;100(18):1290-300. doi: 10.1093/jnci/djn292. Epub 2008 Sep 9.

PMID:
18780864
6.

Costs of breast cancer and the cost-effectiveness of breast cancer screening.

Elixhauser A.

Int J Technol Assess Health Care. 1991;7(4):604-15. Review.

PMID:
1778705
7.

Cost-effectiveness of mammographic screening in Australia.

Carter R, Glasziou P, van Oortmarssen G, de Koning H, Stevenson C, Salkeld G, Boer R.

Aust J Public Health. 1993 Mar;17(1):42-50.

PMID:
8357894
8.

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.

Saadatmand S, Tilanus-Linthorst MM, Rutgers EJ, Hoogerbrugge N, Oosterwijk JC, Tollenaar RA, Hooning M, Loo CE, Obdeijn IM, Heijnsdijk EA, de Koning HJ.

J Natl Cancer Inst. 2013 Sep 4;105(17):1314-21. doi: 10.1093/jnci/djt203. Epub 2013 Aug 12.

PMID:
23940285
9.

Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.

Boer R, de Koning H, Threlfall A, Warmerdam P, Street A, Friedman E, Woodman C.

BMJ. 1998 Aug 8;317(7155):376-9.

10.

The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.

Szeto KL, Devlin NJ.

Health Policy. 1996 Nov;38(2):101-15. Review.

PMID:
10160378
11.

Economic considerations in breast cancer screening of older women.

Brown ML.

J Gerontol. 1992 Nov;47 Spec No:51-8. Review.

PMID:
1430883
12.

Cost-effectiveness of the Norwegian breast cancer screening program.

van Luijt PA, Heijnsdijk EA, de Koning HJ.

Int J Cancer. 2017 Feb 15;140(4):833-840. doi: 10.1002/ijc.30513. Epub 2016 Nov 23.

PMID:
27861849
13.

How cost-effective is breast cancer screening in different EC countries?

van Ineveld BM, van Oortmarssen GJ, de Koning HJ, Boer R, van der Maas PJ.

Eur J Cancer. 1993;29A(12):1663-8.

PMID:
8398290
14.

A model for breast cancer screening.

van Oortmarssen GJ, Habbema JD, van der Maas PJ, de Koning HJ, Collette HJ, Verbeek AL, Geerts AT, Lubbe KT.

Cancer. 1990 Oct 1;66(7):1601-12.

15.

Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB).

De Koning HJ, Fracheboud J, Boer R, Verbeek AL, Collette HJ, Hendriks JH, van Ineveld BM, de Bruyn AE, van der Maas PJ.

Int J Cancer. 1995 Mar 16;60(6):777-80.

PMID:
7896444
16.

A cost utility analysis of mammography screening in Australia.

Hall J, Gerard K, Salkeld G, Richardson J.

Soc Sci Med. 1992 May;34(9):993-1004.

PMID:
1631612
17.

Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.

Feig S.

Radiol Clin North Am. 2010 Sep;48(5):879-91. doi: 10.1016/j.rcl.2010.06.002. Review.

PMID:
20868891
18.

Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.

Jacobi CE, Nagelkerke NJ, van Houwelingen JH, de Bock GH.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):429-36.

19.

Economic aspects of cervical cancer screening.

Koopmanschap MA, Lubbe KT, van Oortmarssen GJ, van Agt HM, van Ballegooijen M, Habbema JK.

Soc Sci Med. 1990;30(10):1081-7.

PMID:
2114040
20.

Costs of home care for advanced breast and cervical cancer in relation to cost-effectiveness of screening.

Koopmanschap MA, van Ineveld BM, Miltenburg TE.

Soc Sci Med. 1992 Oct;35(8):979-85.

PMID:
1411705

Supplemental Content

Support Center